Ellinor Christin Haukland1,2, Christian von Plessen3,4, Carsten Nieder1,5, Barthold Vonen2,6. 1. a Department of Oncology and Palliative Medicine , Nordland Hospital Trust , Bodø , Norway. 2. b Department of Community Medicine , University of Tromsø , Tromsø , Norway. 3. c Centre for Quality , Region of Southern Denmark , Middelfart , Denmark. 4. d Institute of Regional Health Research , University of Southern Denmark , Odense , Denmark. 5. e Department of Clinical Medicine , University of Tromsø , Tromsø , Norway. 6. f Centre for Clinical Documentation and Evaluation , Northern Norway Regional Health Authority , Tromsø , Norway.
Abstract
BACKGROUND:Patients with cancer are often treated by many healthcare providers, receive complex and potentially toxic treatments that can increase the risk for iatrogenic harm. The aim of this study is to investigate whether hospitalised cancer patients are at higher risk of adverse events (AEs) compared to a general hospital population. MATERIAL AND METHODS:A total of 6720 patient records were retrospectively reviewed comparing AEs in hospitalised cancer patients to a general hospital population in Norway, using the IHI Global Trigger Tool method. RESULTS: 24.2 percent of admissions for cancer patients had an AE compared to 17.4% of admissions of other patients (p < .001, rr 1.39, 95% CI 1.19-1.62). However, cancer patients did not have a higher rate of AEs per 1000 patient days compared to other patients, 37.1 vs. 36.0 (p = .65, rr 0.94, 95% CI 0.90-1.18). No particular cancer category is at higher risk. The rate of AEs increases by 1.05 times for each day spent in hospital. For every year increase in age, the risk for AEs increases by 1.3%. Cancer patients more often have hospital-acquired infections, other surgical complications and AEs related to medications. CONCLUSIONS: Because of higher age, longer length of stay and surgical treatment, hospitalised cancer patients experience AEs more often than other patients.
RCT Entities:
BACKGROUND:Patients with cancer are often treated by many healthcare providers, receive complex and potentially toxic treatments that can increase the risk for iatrogenic harm. The aim of this study is to investigate whether hospitalised cancerpatients are at higher risk of adverse events (AEs) compared to a general hospital population. MATERIAL AND METHODS: A total of 6720 patient records were retrospectively reviewed comparing AEs in hospitalised cancerpatients to a general hospital population in Norway, using the IHI Global Trigger Tool method. RESULTS: 24.2 percent of admissions for cancerpatients had an AE compared to 17.4% of admissions of other patients (p < .001, rr 1.39, 95% CI 1.19-1.62). However, cancerpatients did not have a higher rate of AEs per 1000 patient days compared to other patients, 37.1 vs. 36.0 (p = .65, rr 0.94, 95% CI 0.90-1.18). No particular cancer category is at higher risk. The rate of AEs increases by 1.05 times for each day spent in hospital. For every year increase in age, the risk for AEs increases by 1.3%. Cancerpatients more often have hospital-acquired infections, other surgical complications and AEs related to medications. CONCLUSIONS: Because of higher age, longer length of stay and surgical treatment, hospitalised cancerpatients experience AEs more often than other patients.
Authors: Lipika Samal; Srijesa Khasnabish; Cathy Foskett; Katherine Zigmont; Arild Faxvaag; Frank Chang; Marsha Clements; Sarah Collins Rossetti; Anuj K Dalal; Kathleen Leone; Stuart Lipsitz; Anthony Massaro; Ronen Rozenblum; Kumiko O Schnock; Catherine Yoon; David W Bates; Patricia C Dykes Journal: J Patient Saf Date: 2022-07-21 Impact factor: 2.243
Authors: William H Smith; Anish B Parikh; Lihua Li; Mark Sanderson; Mark Liu; Madhu Mazumdar; Luis M Isola; Kavita V Dharmarajan Journal: J Cancer Policy Date: 2020-01-14
Authors: Edmundo Vázquez-Cornejo; Olga Morales-Ríos; Gabriela Hernández-Pliego; Carlo Cicero-Oneto; Juan Garduño-Espinosa Journal: PLoS One Date: 2022-03-24 Impact factor: 3.240